MRNA
NASDAQ · Biotechnology
Moderna Inc
$54.32
-1.94 (-3.44%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+29.49%
1Y
+104.13%
YTD
+76.02%
Open$57.54
Previous Close$56.26
Day High$59.00
Day Low$54.04
52W High$85.60
52W Low$22.28
Volume—
Avg Volume4.62M
Market Cap21.75B
P/E Ratio—
EPS$-8.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.98
Above
SMA 200
$29.64
Above
RSI (14)
57.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
30 analysts
Price Target
+175.1% upside
Current
$54.32
$54.32
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98B | 4.26B | 2.23B |
| Net Income | -2,878,485,820 | -5,564,083,414 | -285,156,561 |
| Profit Margin | -145.2% | -137.9% | -12.8% |
| EBITDA | -2,916,220,192 | -5,950,191,542 | -355,384,473 |
| Free Cash Flow | — | — | -237,052,091 |
| Rev Growth | -53.4% | -53.4% | +3.0% |
| Debt/Equity | 0.07 | 0.07 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |